Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 81-90 of 568 for sleep

Edit search filters
  1. Treatment of RLS/WED Symptoms Through Sensory Counter-stimulation

    Rochester, MN

  2. Study to Assess the Safety and Effectiveness of Oral BTD-001 in Adults with Idiopathic Hypersomnia

    Scottsdale/Phoenix, AZ

  3. A Study of the Safety and Effectiveness of Suvorexant (MK-4305) for the Treatment of Insomnia in People who have Alzheimer's Disease

    Rochester, MN

  4. PRA023 in Subjects with Systemic Sclerosis Associated with Interstitial Lung Disease

    Scottsdale/Phoenix, AZ

  5. Does Pulmonary Rehabilitation Improve Frailty?

    Rochester, MN

  6. Cardiothoracic Resident and Fellow Operative Autonomy (Zwisch Me!)

    Rochester, MN

  7. Sorafenib for Hepatopulmonary Syndrome

    Rochester, MN, Scottsdale/Phoenix, AZ

  8. Phase ll Study of Pirfenidone in Patients With RAILD

    Rochester, MN

  9. Study of Safety of Foradil in Patients with Persistent Asthma

    Rochester, MN

  10. A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC

    Rochester, MN

.

Mayo Clinic Footer